Michael, it's important to distinguish between tests looking for TB antibodies (which is what this report is about), and T-cell based, interferon-Gamma tests (QFT-G).
They are very different, so this report really serves to emphasize the weaknesses of the competition faced by Cellestis. Far from being a negative for CST, it's probably a Buy signal!
report, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
